Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Otolaryngology (Ear, Nose, Throat) | Pulmonary/Respiratory Diseases | Family Medicine
Disease Category: Esophageal Cancer
Location: United States, NJ
Barrett's Esophagus & Gastroesophageal Reflux Disease
This is a study of Barrett's Esophagus (BE) and
Gastroesophageal Reflux Disease (GERD). It aims to look at the long
term efficacy of evidence-based cutting edge diagnostic and
therapeutic algorithms and techniques such as radiofrequency
ablation, endoscopic mucosal resection and surveillance endoscopy
with biopsy. Additionally, biological analyses will be performed in
hopes of identifying biomarkers associated with the progression of
BE to esophageal cancer.
- Male or female, age 18 to 85.
- Patient must have Barrett's Esophagus.
- Patients may be enrolled based on previous endoscopy reports
and/or pathology reports. It is not necessary that each patient
have endoscopy for the sole purpose of enrollment.
- Must agree to allow their clinical information to be collected,
stored, analyzed and reported.
- Must allow portions of their biopsy/surgical specimens to be
collected, stored, analyzed and reported.
- Must agree to fill out patient questionnaires in conjunction
with the research study assistant assigned to this protocol (either
in person or via telephone contact) at designated
Patient Exclusion Criteria:
- Intestinal metaplasia of the cardia, without an esophageal
- Unable to provide informed consent.
- Unable or unwilling to undergo endoscopic procedures.
Barrett's esophagus (BE) is a known premalignant condition of
the esophagus, predisposing to the development of esophageal
adenocarcinoma. BE represents a change in the lining (mucosa) of
the esophagus which is known to be produced as a result of chronic
gastroesophageal reflux. The current standard of care for patients
with BE includes serial performance of upper endoscopy with
multiple biopsies, performed at designated time intervals. However,
the emergence of new technologies for the management of this
condition has made the care of these patients non-uniform, and
subject to biases of individual treating physicians.
The protocol at The Valley Hospital and Blumenthal Cancer Center
aims to standardize the management of patients with Barrett's
esophagus, with and without dysplasia, using evidence-based,
cutting edge diagnostic and therapeutic algorithms and techniques
such as radiofrequency ablation, endoscopic mucosal resection, and
surveillance endoscopy with biopsies. If biopsies suggest the
development of carcinoma or high grade dysplasia surgical removal
of the esophagus is recommended. This study aims to look at the
long-term efficacy of these procedures. In addition, data regarding
clinical outcomes will be collected as well as blood, tissue and
surgical specimens for proteomic analysis in hopes of identifying
biomarkers associated with the progression of dysplasia to
adenocarcinoma. Although patients will ultimately make their own
informed decisions regarding the management of their BE, this
protocol serves to unify physician recommendations, and allows for
the collection and interpretation of data.
Sobeida J. Santana-Joseph, Disease Mgt Teams Coordinator
The Valley Hospital/Valley Health System
Daniel & Gloria Blumenthal Cancer Center
One Valley Health Plaza
Paramus, NJ 07652
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these